Market Research Logo

Ranbaxy Laboratories Limited - Strategy and SWOT Report

Ranbaxy Laboratories Limited - Strategy and SWOT Report

is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Ranbaxy Laboratories Limited required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Ranbaxy Laboratories Limited in the form of a SWOT analysis
  • An in-depth view of the business model of Ranbaxy Laboratories Limited including a breakdown and examination of key business segments
  • Intelligence on Ranbaxy Laboratories Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Ranbaxy Laboratories Limited, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Ranbaxy Laboratories Limited (Ranbaxy or 'the company'), a subsidiary of Daiichi Sankyo, is a leading generic pharmaceutical company in India. It is engaged in the production, distribution and marketing of generics, value-added and over-the-counter (OTC) products, anti-retroviral (ARV), active pharmaceuticals ingredients (API), and intermediates. The company operates in Asia Pacific, Americas, Europe, Middle East and Africa. It is headquartered in Gurgaon, India, and employed 11,784 people as of March 31, 2014. The company recorded revenues of INR132,684.8 million (approximately $2,255.6 million) during the 15-month period ended March 31, 2014. The operating profit of the company was INR6,851.5 million (approximately $116.4 million) and the net loss was INR10,852.5 million (approximately $184.5 million) during the 15-month period. Ranbaxy changed its financial year from January–December to April–March, and reported financial for the 15-month period ended March 31, 2014. Hence, the company’s financials for the 15-month period cannot be compared with the financials of FY2012. In April 2014, Ranbaxy and Sun Pharmaceutical Industries (Sun Pharma), an India-based leading generic manufacturer, entered into definitive agreements pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction.

Reasons to Purchase:
  • Gain understanding of Ranbaxy Laboratories Limited and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Ranbaxy Laboratories Limited as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Ranbaxy Laboratories Limited’s business structure, strategy and prospects


Company Snapshot
Ranbaxy Laboratories Limited: Company Overview
Ranbaxy Laboratories Limited: Overview and Key Facts
Ranbaxy Laboratories Limited: Overview
Ranbaxy Laboratories Limited: Key Facts
Ranbaxy Laboratories Limited: Key Employees
Ranbaxy Laboratories Limited: Key Employee Biographies
Ranbaxy Laboratories Limited: Major Products and Services
Ranbaxy Laboratories Limited: Company History
Ranbaxy Laboratories Limited: Management Statement
Ranbaxy Laboratories Limited: Locations and Subsidiaries
Ranbaxy Laboratories Limited: Key Competitors
Ranbaxy Laboratories Limited: Company Analysis
Ranbaxy Laboratories Limited: Business Description
Ranbaxy Laboratories Limited: SWOT Analysis
Ranbaxy Laboratories Limited: SWOT Overview
Ranbaxy Laboratories Limited: Strengths
Ranbaxy Laboratories Limited: Weaknesses
Ranbaxy Laboratories Limited: Opportunities
Ranbaxy Laboratories Limited: Threats
Ranbaxy Laboratories Limited: Corporate Financial Deals Activity
Ranbaxy Laboratories Limited: Financial Deals Overview
Ranbaxy Laboratories Limited: Targets and Partners
Ranbaxy Laboratories Limited: Top Deals 2011 - 2015YTD*
Ranbaxy Laboratories Limited: Advisors
Ranbaxy Laboratories Limited: Top Legal Advisors
Ranbaxy Laboratories Limited: Top Financial Advisors
Ranbaxy Laboratories Limited: Mergers and Acquisitions
Ranbaxy Laboratories Limited: Partnership
Ranbaxy Laboratories Limited: Private Equity and Ownership
Ranbaxy Laboratories Limited: Recent Developments
Ranbaxy Laboratories Limited: News and Events Summary
Ranbaxy Laboratories Limited: Business Expansion
Ranbaxy Laboratories Limited: Contracts
Ranbaxy Laboratories Limited: Financial Deals
Ranbaxy Laboratories Limited: Financial Performance
Ranbaxy Laboratories Limited: Regulatory and Legal Events
Ranbaxy Laboratories Limited: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine
List of Tables
Table 1: Ranbaxy Laboratories Limited: Key Facts
Table 2: Ranbaxy Laboratories Limited: Key Employees
Table 4: Ranbaxy Laboratories Limited: Key Competitors
Table 5: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Table 7: Ranbaxy Laboratories Limited: M&A Average Deal Size - Value (US$m)
Table 8: Ranbaxy Laboratories Limited: Targets and Partners
Table 9: Ranbaxy Laboratories Limited: Top Deals 2011 - 2015YTD*
Table 10: Ranbaxy Laboratories Limited: Legal Advisor Ranking by Value (US$m)
Table 11: Ranbaxy Laboratories Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Ranbaxy Laboratories Limited: M&A Volume and Value Trend (2011 - YTD*2015)
Table 13: Ranbaxy Laboratories Limited: M&A Activity by Geography (2011 - YTD*2015)
Table 14: Ranbaxy Laboratories Limited: Partnership Volume and Value Trend (2011 - YTD*2015)
Table 15: Ranbaxy Laboratories Limited: Partnership Trend by Deal Type (2011 - YTD*2015)
Table 16: Ranbaxy Laboratories Limited: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Table 17: Ranbaxy Laboratories Limited: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
Table 18: Ranbaxy Laboratories Limited: News and Events Summary
Table 19: Ranbaxy Laboratories Limited: Business Expansion
Table 20: Ranbaxy Laboratories Limited: Contracts
Table 21: Ranbaxy Laboratories Limited: Financial Deals
Table 22: Ranbaxy Laboratories Limited: Financial Performance
Table 23: Ranbaxy Laboratories Limited: Regulatory and Legal Events
Table 24: Ranbaxy Laboratories Limited: Strategy and Operations
List of Figures
Figure 1: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ranbaxy Laboratories Limited: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Figure 3: Ranbaxy Laboratories Limited: M&A Average Deal Size - Value (US$m)
Figure 4: Ranbaxy Laboratories Limited: M&A Volume and Value Trend (2011 - YTD*2015)
Figure 5: Ranbaxy Laboratories Limited: M&A Activity by Geography (2011 - YTD*2015)
Figure 6: Ranbaxy Laboratories Limited: Partnership Volume and Value Trend (2011 - YTD*2015)
Figure 7: Ranbaxy Laboratories Limited: Partnership Trend by Deal Type (2011 - YTD*2015)
Figure 8: Ranbaxy Laboratories Limited: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Figure 9: Ranbaxy Laboratories Limited: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report